We are live on ! Find out more
NMTR

9 Meters Biopharma
NMTR

Delisted

NMTR was delisted on the 25th of July, 2023.

Back to rankings

6 hedge funds and large institutions have $22.7K invested in 9 Meters Biopharma in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

82% less funds holding

Funds holding: 34 → 6 (-28)

99% less capital invested

Capital invested by funds: $2.08M → $22.7K (-$2.05M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 28

Holders
6
Holders Change
-28
Holders Change %
-82.35%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
–
Closed
28
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$298K
2
SIS
Strategic Investment Solutions
Illinois
+$8.01K

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$437K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$417K
3
LCM
Laurion Capital Management
New York
-$147K
4
BlackRock
BlackRock
New York
-$113K
5
Geode Capital Management
Geode Capital Management
Massachusetts
-$73.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$20.1K +$298K +634,187 +61%
SIS
2
Strategic Investment Solutions
Illinois
$2.28K +$8.01K +17,050 +6,200%
RCM
3
Requisite Capital Management
Texas
$180 – – –
BCMLT
4
Beacon Capital Management LLC (Tennessee)
Tennessee
$104 – – –
SPIA
5
Steward Partners Investment Advisory
New York
$13 – – –
RFA
6
Register Financial Advisors
Georgia
$1 – – –
Adage Capital Partners
7
Adage Capital Partners
Massachusetts
– -$437K -650,000 Closed
Vanguard Group
8
Vanguard Group
Pennsylvania
– -$417K -619,829 Closed
LCM
9
Laurion Capital Management
New York
– -$147K -218,710 Closed
BlackRock
10
BlackRock
New York
– -$113K -167,949 Closed
Geode Capital Management
11
Geode Capital Management
Massachusetts
– -$73.1K -108,821 Closed
State Street
12
State Street
Massachusetts
– -$34.2K -50,908 Closed
ODFS
13
O'Donnell Financial Services
California
– -$29.2K -43,410 Closed
Commonwealth Equity Services
14
Commonwealth Equity Services
Massachusetts
– -$25K -37,905 Closed
CIBC Asset Management
15
CIBC Asset Management
Ontario, Canada
– -$22K -32,722 Closed
Northern Trust
16
Northern Trust
Illinois
– -$14.4K -21,461 Closed
Susquehanna International Group
17
Susquehanna International Group
Pennsylvania
– -$11.5K -17,089 Closed
Renaissance Technologies
18
Renaissance Technologies
New York
– -$10K -15,180 Closed
TSS
19
Two Sigma Securities
New York
– -$9.3K -13,844 Closed
Cerity Partners
20
Cerity Partners
New York
– -$7.2K -10,708 Closed
Group One Trading
21
Group One Trading
Illinois
– -$6.96K -10,363 Closed
TRCT
22
Tower Research Capital (TRC)
New York
– -$4.51K -6,709 Closed
Bank of America
23
Bank of America
North Carolina
– -$3.85K -5,733 Closed
Morgan Stanley
24
Morgan Stanley
New York
– -$1.99K -2,962 Closed
Citadel Advisors
25
Citadel Advisors
Florida
– -$933 -1,388 Closed
1
2

NMTR Hedge Fund Activity: Q3 2023 in Review

6 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in 9 Meters Biopharma (NMTR) for Q3 2023, worth a combined $22.7K — down 99% from $2.08M a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of NMTR and 0 opened new positions — a net loss of 28 holders — while 0 trimmed existing stakes and 2 added.

The largest buyer was Sabby Management, adding an estimated $298K. The largest seller was Adage Capital Partners, exiting entirely with an estimated $437K sold.

  • 6 institutional investors held 9 Meters Biopharma (NMTR) as of Q3 2023, down from 34 in Q2 2023.
  • Funds reported $22.7K of 9 Meters Biopharma stock for Q3 2023, down 99% quarter-over-quarter.
  • 0 funds opened new 9 Meters Biopharma positions in Q3 2023 and 28 closed out, a net change of -28 holders.
  • The largest 9 Meters Biopharma buyer in Q3 2023 was Sabby Management, an estimated $298K added.
  • The largest 9 Meters Biopharma seller in Q3 2023 was Adage Capital Partners, an estimated $437K sold.

Based on aggregated 13F filings for Q3 2023.